Woodline Partners LP Incyte Corp Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Incyte Corp stock. As of the latest transaction made, Woodline Partners LP holds 794,773 shares of INCY stock, worth $61.8 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

794,773

Previous 1,154,214 31.14%

Holding current value

$61.8 Million

Previous $70 Million 24.92%

% of portfolio

0.48%

Previous 0.7%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $20.6 Million - $24.7 Million	-359,441 Reduced 31.14%	794,773 $52.5 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $1.06 Million - $1.32 Million	20,722 Added 1.83%	1,154,214 $70 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $38,171 - $44,948	675 Added 0.06%	1,133,492 $64.6 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $32.9 Million - $40.5 Million	630,852 Added 125.68%	1,132,817 $71.1 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $113,518 - $129,552	1,965 Added 0.39%	501,965 $29 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $5.65 Million - $7 Million	-92,756 Reduced 15.65%	500,000 $31.1 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $39.8 Million - $49.9 Million	592,756 New	592,756 $47.6 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $18.1 Million - $21.9 Million	-274,786 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $17.4 Million - $20.4 Million	274,786 New	274,786 $20.2 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $9.62 Million - $12.7 Million	-126,508 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $10.2 Million - $12.4 Million	126,508 New	126,508 $11 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $13.6 Million - $18.6 Million	-216,001 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $15.8 Million - $20.7 Million	216,001 New	216,001 $18.9 Million

Others Institutions Holding INCY

# of Institutions

640

Shares Held

187M

Call Options Held

729K

Put Options Held

479K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Incyte Corp Transaction History